Shelter Pharma Limited has announced its unaudited financial results for the half year ended September 30, 2025, showcasing a mixed performance compared to the previous year. The pharmaceutical manufacturer reported a profit before tax of Rs 601.45 crore, down from Rs 967.70 crore in the corresponding period last year.

Financial Highlights

Despite the decrease in revenue and profit before tax, the company's basic earnings per share (EPS) improved to Rs 3.89, up from Rs 3.06 in the previous year, indicating a 27.1% increase.

Balance Sheet Strengthens

Shelter Pharma's balance sheet showed signs of growth:

• Total assets increased to Rs 6,689.54 crore as of September 30, 2025, up from Rs 4,833.55 crore on March 31, 2025.
• Reserves and surplus grew to Rs 3,561.47 crore from Rs 3,116.08 crore.
• The company received Rs 1,350.84 crore as money against share warrants.

Operational Performance

The cost of material consumed stood at Rs 2,490.11 crore for the half-year period. Employee benefit expenses were reported at Rs 85.40 crore, while other expenses amounted to Rs 120.72 crore.

Cash Flow and Liquidity

The company's cash and cash equivalents at the end of the period stood at Rs 527.96 crore, showing a significant increase from Rs 341.99 crore at the beginning of the year. This improvement in liquidity may provide the company with more flexibility for future investments and operations.

Corporate Governance

The Board of Directors approved these results in a meeting held on November 10, 2025. The company reported no investor complaints during the review period, reflecting positively on its investor relations practices.

Utilization of Funds

According to the auditor's report, Shelter Pharma has fully utilized the Rs 930.35 crore raised through a preferential issue of convertible warrants into equity shares for working capital requirements, with no deviation from the stated objectives.

Shelter Pharma continues to operate in the pharmaceutical manufacturing sector, facing challenges in revenue growth but maintaining profitability and strengthening its balance sheet.

Shelter Pharma Limited has taken a significant step towards sustainable manufacturing by installing a 15 KW solar power plant at its factory in Himmatnagar, Gujarat. This move aligns with the company's commitment to eco-friendly practices and long-term cost savings.

Solar Installation Details

The solar power plant, installed on the factory roof at Shelter Nagar, near S. T. Bus Stand, Himmatnagar, Gujarat, is designed to harness renewable energy for the company's manufacturing operations. With an expected lifespan of 25 years, this installation marks a pivotal moment in Shelter Pharma's sustainability journey.

Financial and Environmental Impact

Shelter Pharma Limited projects a quick return on investment for this green initiative:

This strategic move not only demonstrates the company's commitment to reducing its carbon footprint but also positions it for significant long-term cost benefits.

Company's Stance on Sustainability

Mustaqim Nisarahmed Sabugar, Managing Director of Shelter Pharma Limited, stated in the company's disclosure, "The installation of the solar power plant underscores Shelter Pharmaceuticals Limited's commitment to innovation, sustainability, and responsible corporate citizenship."

About Shelter Pharma Limited

Shelter Pharma Limited is a prominent player in the pharmaceutical and nutraceutical sector, known for its focus on research, innovation, and quality. The company aims to provide accessible and effective healthcare solutions while maintaining high industry standards. With state-of-the-art facilities and a team of experts, Shelter Pharma is dedicated to producing safe and effective products that enhance the quality of life for individuals globally.

This solar power plant installation is a testament to Shelter Pharma's dedication to sustainable practices and its vision for a greener future in pharmaceutical manufacturing.